entir
repertoir
antibodi
serum
igom
histor
record
past
experi
reflect
immun
statu
given
moment
understand
dynam
igom
divers
specif
serum
antibodi
chang
respons
diseas
mainten
homeostasi
directli
impact
abil
design
develop
novel
vaccin
diagnost
therapeut
review
direct
indirect
methodolog
develop
map
complex
specif
antibodi
polyclon
serum
igom
jm
gershoni
feb
letter
j
u
r
n
l
h
e
p
g
e
w
w
w
f
e
b
l
e
e
r
r
g
centuri
pass
sinc
first
nobel
prize
medicin
award
emil
von
behr
work
serum
therapi
open
new
road
domain
medic
scienc
therebi
place
hand
physician
victori
weapon
ill
death
serum
inde
victori
weapon
abl
neutral
pathogen
exquisit
specif
antibodi
seem
endless
capac
discrimin
bind
vast
structur
complex
found
natur
susumu
tonegawa
nobel
prize
recogn
elucid
genet
principl
gener
antibodi
divers
applic
principl
allow
deriv
total
potenti
repertoir
antibodi
human
combinatori
multipl
v
j
segment
heavi
h
chain
time
combin
product
v
j
segment
kappa
lambda
light
l
chain
well
contribut
n
p
nucleotid
associ
junction
complex
lead
extraordinari
vast
theoret
number
far
exce
total
number
bcell
person
bodi
realist
avail
repertoir
variant
bcell
calcul
order
per
person
mani
bcell
subtyp
actual
util
product
distinct
antibodi
probabl
exceed
ten
thousand
person
life
time
surprisingli
wherea
pathogen
come
go
clear
bodi
antibodi
gener
respons
immunolog
insult
archiv
memori
bcell
cell
orchestr
continu
product
antibodi
found
serum
cours
live
entir
util
repertoir
antibodi
serum
igom
histor
record
past
experi
reflect
immun
statu
given
moment
understand
igom
homeostasi
maintain
serum
memori
affect
immun
boost
encount
pathogen
physiolog
old
age
fundament
question
great
interest
answer
question
bear
directli
develop
novel
vaccin
diagnost
therapeut
order
meet
challeng
one
must
abl
profil
igom
need
abl
describ
igom
entireti
singl
antibodi
resolut
manner
cost
effect
expedi
one
could
imagin
run
igom
screen
routin
cours
person
medic
diagnosi
treatment
obvious
challeng
formid
consid
divers
antibodi
dynam
express
given
moment
result
given
stimulu
review
varieti
technic
approach
design
profil
serum
antibodi
divers
quest
describ
complex
composit
human
igom
two
basic
differ
approach
employ
analysi
antibodi
repertoir
serum
direct
approach
goe
profil
antibodi
antibodyproduc
cell
one
catalogu
antibodi
base
proteom
sequenc
achiev
genom
sequenc
antibodi
transcript
deriv
peripher
bcell
ultim
goal
would
rank
antibodi
rel
concentr
categor
antigen
specif
indirect
approach
use
surrog
measur
extrapol
antibodi
speci
base
protein
peptid
bind
henc
igom
profil
would
list
infer
antibodi
specif
first
address
direct
analysi
igom
conceptu
profil
igom
entireti
would
complet
one
abl
systemat
clone
antibodi
polyclon
serum
one
one
catalogu
frequenc
usag
along
correspond
antigen
specif
clearli
classic
method
product
monoclon
antibodi
mab
suitabl
massiv
comprehens
screen
mice
definit
human
see
exampl
review
introduct
phage
display
librari
antibodi
howev
provid
breakthrough
one
could
theori
preserv
entir
repertoir
heavi
h
light
l
chain
person
later
screen
variou
antigen
specif
two
type
antibodi
phage
display
librari
construct
immun
librari
type
librari
gener
discov
detail
immun
respons
given
pathogen
autoimmun
diseas
cancer
librari
gener
random
donor
presum
repres
healthi
human
repertoir
antibodi
gener
principl
librari
offer
possibl
select
high
affin
antibodi
desir
specif
without
need
select
stimul
immun
respons
specif
antigen
use
librari
consider
success
isol
mab
variou
pathogen
sarscov
wnv
hbv
second
class
librari
immun
phagedisplay
antibodi
librari
construct
mrna
donor
expos
infectionvaccin
defin
antigen
therefor
immun
respons
specif
stimul
immun
librari
gener
prefer
use
donor
high
serum
antibodi
titer
antigenpathogen
interest
high
serum
titer
presum
reflect
rel
high
level
ab
product
therefor
higher
level
specif
mrna
obtain
gener
librari
approach
success
isol
mab
specif
divers
pathogen
foot
mouth
diseas
hiv
matter
isol
potent
neutral
mab
success
use
immun
librari
compar
librari
construct
select
donor
proven
neutral
activ
case
point
studi
burton
barba
antibodi
librari
produc
old
posit
homosexu
male
asymptomat
six
year
fab
librari
construct
surfac
filament
phage
compris
member
librari
screen
monomer
glycosyl
iiib
collect
phage
display
mab
isol
potent
mab
compet
bind
site
receptor
thu
prevent
viru
bind
target
cell
cocrystal
mab
core
confirm
epitop
overlap
bind
site
moreov
studi
reveal
two
major
drawback
phage
display
technolog
methodolog
still
rel
time
consum
tediou
somewhat
ineffici
typic
standard
experi
ten
mab
isol
specif
toward
antigen
screen
ii
natur
pair
immunoglobulin
h
l
chain
lost
construct
librari
thu
vast
major
antibodi
produc
result
random
arbitrari
pair
reflect
natur
h
l
pair
bcell
clone
produc
inde
cocrystal
mab
show
l
chain
contribut
recognit
contact
made
exclus
via
h
chain
thu
indic
l
chain
use
probabl
h
chain
natur
partner
gener
estim
construct
ab
phage
display
librari
total
h
l
chain
cdna
deriv
peripher
blood
mononuclear
cell
pbmc
gener
complex
phage
display
antibodi
mab
expect
maintain
nativ
h
l
pair
anoth
drawback
phage
display
antibodi
system
vh
vl
pair
may
toxic
impair
bacteri
growth
turn
may
lead
bias
represent
antibodi
phage
display
use
antibodi
express
nonetheless
power
phagedisplay
antibodi
librari
abil
immort
entireti
avail
potenti
h
l
chain
even
expand
upon
gener
novel
pair
natur
exist
donor
repertoir
premis
analys
one
appli
next
gener
sequenc
ng
catalogu
entir
complex
antibodi
relat
transcript
given
individu
high
throughput
sequenc
typic
perform
use
pyrosequenc
analys
current
gener
sequenc
bp
long
thu
one
read
beyond
three
cdr
chain
singl
run
total
pbmc
use
analys
typic
address
avail
repertoir
necessarili
util
repertoir
thu
exampl
glanvil
et
al
conduct
analys
pool
phage
display
igm
antibodi
deriv
healthi
human
donor
studi
serv
comprehens
detail
analysi
avail
igom
produc
baselin
sort
averag
human
repertoir
total
divers
combinatori
ab
librari
calcul
librari
screen
use
differ
antigen
produc
collect
antigen
specif
antibodi
analyz
use
ng
found
compris
human
germlin
vdj
vj
segment
expect
moreov
analysi
provid
insight
rel
frequenc
usag
v
segment
applic
ng
studi
antibodi
increas
understand
gener
physic
trait
antibodi
produc
human
preval
usag
variou
germlin
v
j
segment
given
class
antigen
anoth
subject
interest
specif
focu
character
loop
regard
amino
acid
length
number
indel
detect
gener
extend
loop
moreov
emphas
power
ng
technolog
provid
qualiti
assur
identifi
correct
bias
may
introduc
procedur
librari
construct
represent
absenc
specif
segment
furthermor
conduct
analys
one
identifi
clonotyp
bcell
defin
transcript
ident
germlin
v
j
segment
usag
ident
amino
acid
length
least
amino
acid
homolog
clonotyp
rank
base
frequenc
given
serum
sampl
moreov
suggest
rank
frequenc
h
clonotyp
vs
l
clonotyp
one
infer
natur
h
l
pair
analysi
util
repertoir
one
must
resort
method
sort
memori
bcell
sourc
mrna
transcript
compar
transcript
correspond
igm
vs
igg
exampl
studi
wu
et
al
ng
analys
two
hiv
infect
individu
ca
sequenc
util
identifi
vh
sequenc
resembl
sequenc
highli
potent
neutral
mab
compar
sequenc
obtain
patient
sequenc
could
follow
affin
matur
pathway
lead
uniqu
class
antibodi
similar
studi
use
ng
address
matur
hiv
specif
mab
report
other
although
ng
analys
total
rna
allow
natur
pair
vh
vl
chain
determin
antibodi
specif
teach
gener
structur
characterist
antibodi
repertoir
given
person
respons
given
clinic
statu
thu
exampl
sera
peopl
infect
specif
pathogen
suffer
cancer
autoimmun
diseas
compar
controlsera
might
lead
identif
specif
marker
use
exampl
diagnost
applic
sinc
sever
new
improv
techniqu
isol
human
mab
emerg
within
limit
period
burst
innov
driven
field
isol
limit
product
hundr
mab
start
sort
antigenspecif
memori
bcell
abil
perform
singl
cell
pcr
transcript
amplif
eventu
effect
clone
express
ig
h
ig
l
gene
deriv
individu
bcell
success
novel
technolog
base
primarili
two
major
develop
improv
sourc
mrna
use
singl
cell
memori
bcell
sourc
rna
particular
signific
work
lanzavecchia
cowork
discov
memori
bcell
prolifer
secret
antibodi
respons
cpg
oligonucleotid
without
need
antigen
stimul
furthermor
memori
bcell
effici
sort
base
surfac
marker
display
igg
iga
lack
pave
way
proven
effect
method
select
antigen
specif
mab
given
individu
case
point
studi
walker
et
al
first
screen
hiv
infect
individu
potent
serum
cross
neutral
activ
identifi
particularli
effect
donor
memori
b
cell
clade
ainfect
african
patient
oppos
glanvil
et
al
use
donor
pool
togeth
use
highthroughput
neutral
screen
antibodycontain
cultur
supernat
approxim
activ
memori
b
cell
donor
led
isol
two
novel
broadli
cross
neutral
mab
ii
improv
design
primer
broadli
cross
neutral
mab
hiv
discov
contain
except
high
level
point
mutat
acquir
cours
somat
hypermut
affin
matur
result
hypervari
interfer
isol
mab
transcript
order
overcom
problem
scheid
et
al
redesign
set
primer
primer
set
upstream
avoid
hypermut
region
appli
approach
led
success
clone
isol
character
new
antibodi
hiv
envelop
bind
memori
b
cell
four
hiv
infect
individu
henc
remark
improv
effici
mab
isol
realiz
obvious
dramat
increas
number
antibodi
isol
distinct
affin
along
sequenc
one
identifi
gener
immun
system
respond
abl
neutral
given
viru
sinc
studi
walker
et
al
number
group
report
variat
conform
gener
paradigm
one
screen
affin
select
memori
bcell
follow
singl
cell
clone
cognat
h
l
chain
guid
construct
function
antibodi
via
recombin
dna
technolog
wherea
mani
analys
discuss
thu
far
dealt
genet
base
ab
product
express
necessarili
address
actual
physic
natur
antibodi
express
serum
henc
combin
proteom
ng
next
step
despit
eleg
singl
cell
clone
natur
mab
memori
bcell
effort
go
produc
select
antigen
specif
mab
rather
provid
insight
gener
divers
antibodi
physic
present
use
serum
address
challeng
deconvolut
divers
ab
present
polyclon
serum
two
group
success
proven
feasibl
combin
proteom
ng
techniqu
analysi
serum
antibodi
respons
although
still
specif
antigen
cheung
et
al
conduct
studi
investig
mab
composit
polyclon
serum
rabbit
immun
progesteron
ab
pr
ab
peptid
wine
et
al
aim
deconvolut
polyclon
serum
rabbit
immun
concholepa
concholepa
hemocyanin
cch
oppos
unimmun
rabbit
case
follow
gener
scheme
use
serum
immunoglobulin
purifi
protein
column
subject
antigen
affin
chromatographi
isol
antigen
specif
igg
purifi
ab
fraction
analyz
liquid
chromatographi
coupl
tandem
mass
spectrometri
lcmsm
parallel
effort
highthroughput
dna
sequenc
immun
anim
memori
bcell
h
l
chain
perform
creat
comprehens
data
base
immunoglobulin
express
archiv
compar
two
data
set
one
draw
number
conclus
one
ascrib
defin
proteom
analysi
full
length
vh
chain
deriv
ng
data
ii
full
length
vh
sequenc
identifi
rank
base
frequenc
map
proteom
analysi
iii
use
differ
strategi
one
reconstitut
antibodi
base
frequent
vh
chain
identifi
group
pioneer
physic
character
antibodi
repres
igom
serum
accomplish
combin
proteom
ng
data
set
thu
illustr
gener
approach
feasibl
wherea
studi
extrem
import
technolog
yet
develop
order
allow
transit
antigen
base
igom
analysi
gener
comprehens
analys
total
igom
given
person
certainli
product
analys
antibodi
come
long
way
sinc
milstein
introduc
murin
hybridoma
technolog
recent
isol
targetspecif
human
mab
deriv
singl
memori
bcell
clone
ultim
comprehens
proteomicng
screen
describ
cheung
wine
howev
effort
still
much
singl
antigen
orient
provid
broader
appreci
divers
antibodi
specif
actual
found
serum
combinatori
peptid
protein
array
propos
perfect
focu
use
phage
display
peptid
librari
review
deal
synthet
peptid
array
antigen
array
reader
refer
specif
review
georg
smith
pioneer
concept
use
random
peptid
display
filament
bacteriophag
interrog
antibodi
initi
applic
studi
map
mab
specif
epitop
via
peptid
abl
affin
select
vast
collect
random
short
peptid
amino
acid
long
exercis
first
taught
us
strike
realiz
despit
notion
exquisit
specif
mab
realiti
turn
given
mab
often
bind
rather
larger
divers
peptid
often
show
obviou
homolog
linear
amino
acid
sequenc
mab
cognat
antigen
due
fact
antibodi
bind
protein
surfac
compris
discontinu
residu
brought
togeth
protein
fold
henc
typic
epitop
conform
discontinu
thu
often
peptid
fish
random
peptid
librari
specif
bind
peptidomimet
fashion
repres
complex
surfac
antigen
recogn
mab
one
must
consid
howev
antibodi
alway
bind
protein
epitop
thu
exampl
probe
phosphotyrosin
oppos
phosphoserin
phospothreonin
develop
illustr
antibodi
target
modifi
amino
acid
moreov
antibodi
often
specif
glycomoieti
case
immun
respons
abo
blood
type
phage
display
peptid
librari
express
bacteria
obvious
account
post
translat
modif
protein
nonetheless
phage
display
peptid
analys
sugar
specif
antibodi
proven
feasibl
often
affin
purifi
peptid
mimet
nonamino
acid
structur
howev
random
peptid
analys
gener
collect
affin
purifi
peptid
repres
given
mab
epitop
thu
number
comput
method
develop
peptid
affin
select
given
mab
use
databas
predict
correspond
epitop
provid
atom
structur
antigen
avail
case
point
applic
predict
algorithm
mapitop
appli
predict
compon
epitop
hiv
neutral
mab
mention
sarscov
neutral
epitop
predict
subsequ
confirm
xray
analys
antibodyantigen
cocryst
folorgi
et
al
first
demonstr
use
phage
display
librari
analysi
diseas
associ
polyclon
serum
investig
screen
librari
random
nonapeptid
use
human
sera
taken
individu
vaccin
hepat
b
viru
surfac
antigen
hbsag
compar
sera
taken
healthi
donor
illustr
panel
peptid
could
produc
correspond
viral
antigen
sinc
studi
dissect
interrog
humor
respons
seen
polyclon
serum
random
phage
display
becom
tool
epitop
map
diagnost
prognost
variou
clinic
state
detail
tabl
previous
discuss
use
phage
display
antibodi
screen
process
long
tediou
process
result
select
ten
hundr
affin
select
peptid
week
screen
moreov
given
mab
select
divers
ten
peptid
gener
panel
even
hundr
peptid
serum
faith
repres
complex
polyclon
composit
order
address
issu
deeppan
propos
method
power
ng
combin
flexibl
random
peptid
phage
display
analysi
polyclon
serum
conceptu
polyclon
serum
use
screen
phage
display
random
peptid
librari
follow
ng
affin
captur
phage
output
analysi
vast
collect
thousand
million
peptid
sequenc
affin
purifi
antibodi
given
serum
sampl
frequenc
specif
peptid
isol
indic
titer
affin
correspond
antibodi
deeppan
isol
clone
singl
phage
rather
entir
complex
phage
harvest
pan
experi
directli
sequenc
moreov
deepsequenc
allow
parallel
sequenc
ten
sampl
sampl
discrimin
short
dna
barcod
base
introduc
pcr
sampl
prepar
exampl
use
deeppan
analysi
infect
polyclon
serum
phage
display
librari
mer
peptid
use
biopan
sampl
purifi
human
igg
obtain
infect
individu
hivig
three
round
biopan
hivig
elut
phage
use
templat
pcr
amplif
pcr
product
deepsequenc
use
illumina
system
total
peptid
obtain
uniqu
sequenc
peptid
could
demonstr
correspond
hiv
envelop
show
deeppan
diseas
relat
serum
gener
clear
diagnost
signal
indic
specif
epitop
associ
pathogen
thu
deeppan
illustr
compat
combinatori
phage
display
librari
ng
comprehens
panel
hundr
thousand
affin
select
phage
display
peptid
produc
frequenc
motif
relev
enabl
one
categor
specif
given
polyclon
serum
develop
comput
algorithm
abl
handl
massiv
data
gener
random
peptid
librari
catalogu
peptid
motif
could
lead
abil
associ
defin
epitop
antigen
thu
deeppan
becom
practic
tool
profil
igom
contrast
random
peptid
display
genefrag
phage
display
librari
offer
altern
simplifi
analys
especi
one
focus
specif
antigen
genefrag
phage
display
librari
repres
gene
cdna
even
total
genom
encod
ligand
interest
dna
reduc
smaller
gene
fragment
bp
usual
dnaseimedi
random
digest
gene
fragment
synthesi
clone
terminu
coat
protein
gene
phage
genefrag
phage
display
librari
use
biopan
polyclon
serum
specif
mab
result
isol
peptid
enabl
one
determin
correspond
epitop
ab
test
select
peptid
also
util
biomark
variou
applic
novel
biomark
circul
auto
antibodi
signatur
may
improv
diagnosi
prognosi
treatment
cancer
autoimmun
infectiousdiseas
exampl
chatterje
et
al
util
cdna
phage
display
librari
identifi
diagnost
marker
ovarian
cancer
select
clone
interact
sera
ovarian
cancer
patient
sera
healthi
women
patient
suffer
benign
malign
gynecolog
diseas
thu
panel
biomark
found
effici
detect
ovarian
cancer
howev
platform
limit
well
abund
fragment
clone
often
read
frame
consequ
identif
epitop
straightforward
exampl
clone
select
chatterje
et
al
could
clearli
shown
correspond
linear
segment
known
antigen
remain
clone
either
unidentifi
weak
homolog
known
protein
thu
assum
repres
mimet
complic
conform
epitop
although
librari
limit
divers
oppos
random
peptid
librari
approach
proven
inexpens
highthroughput
moreov
method
allow
direct
map
epitop
antigen
sequenc
oppos
phage
display
random
peptid
librari
epitop
map
straight
forward
tour
de
forc
demonstr
regard
gene
fragment
studi
larman
et
al
emphas
strength
combin
deepsequenc
phage
display
investig
construct
complet
human
proteom
form
tile
overlap
peptid
synthet
represent
proteom
gener
phage
display
librari
made
dna
sequenc
encod
amino
acid
peptid
span
uniqu
open
read
frame
dna
oligonucleotid
robot
synthes
clone
use
phage
display
system
final
librari
obtain
screen
spinal
fluid
patient
suffer
neurolog
autoimmun
diseas
screen
result
identif
autoantigen
candid
four
consid
potenti
diagnost
marker
author
propos
improv
methodolog
may
realiz
construct
peptid
greater
length
could
extend
analys
conform
epitop
direct
indirect
method
use
profil
complex
composit
antibodi
polyclon
serum
present
technolog
proven
effici
appli
humor
respons
toward
specif
antigen
pathogen
nonetheless
exampl
discuss
serv
practic
illustr
abl
cope
vast
divers
antibodi
compris
igom
much
progress
made
antibodi
isol
molecular
character
antigenspeptid
bind
refin
method
describ
lead
distant
futur
comprehens
portray
human
igom
discoveri
potenti
serum
biomark
earli
primari
hepatocellular
carcinoma
hcc
